What are the risks or complications of GLP-1 agonists?

What are the risks or complications of GLP-1 agonists?

Risk information for GLP-1 agonists lives on each medicine's label and on the government pages linked below. Read the label for the medicine you are offered, then bring your questions to your prescriber.

Where the risk information lives

Start with the medicine's own label and patient information. MedlinePlus has a drug information page for semaglutide injection that covers use, precautions and side effects. The NIDDK page on prescription medications for overweight and obesity compares options at a general level. For a regulatory view, read the FDA announcement on a chronic weight management medication and the FDA's concerns with unapproved GLP-1 drugs, which matters if you are buying from a source you have not checked.

Asking ahead about missed doses and symptoms

If you are on a GLP-1 medicine, read the directions for missed doses and for travel before you need them, and keep the label handy. Tell your prescriber about every other medicine you take. Ask them what to do if you miss a dose and which symptoms mean you should call right away.

Why your own label outranks general reading

Label warnings are where to look before a trip or busy week, and general reading does not replace the risk list for your own medicine. Do not start, stop or change a medicine based on something you read online.